Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Please correct me if I'm wrong but with the reverse split, this will now be valued at approximately forty cents at present value. Makes it more welcome to the brokers who house it for shareholders. Likely folks have had to transfer or dump it once it got to less than a penny.
Agreeing with HR for a second time, at 300,000 shares trading, usually less, no one is selling but no one is buying.
RAD Shares will go up if deal cancelled, only down because of present terms of deal.
Up big on large volume, that's a NICE change!
How many times here have posters said shareholders have already got screwed by this deal? I say, what deal?
IMPORTANT: Just because someone makes an offer doesn't mean it's a deal!
I would say it's great that RAD looks attractive to ANY suitor. If we choose to sell, that might be nice but we should have faith that the deal will close for the best terms. There's a fiduciary responsibility for that to happen and I understand the lawyers are already prematurely circling their wagons after all.
The game is afoot. The offer is not accepted, the shareholders are not screwed.
Shareholders still have to approve and I don't see how or why a first offer would be snapped up, especially when you can see how the market is valuing the original. With the Walgreens debt pay down, RAD no longer needs a deal. My prediction is RAD will be highly volatile in the $2-3 range as speculation goes back and forth until make or break.
Bottomline: Albertson's wants and maybe even needs RAD...but not the other way around.
Tim repeated his "BUY" two more times last week during the market's bloodbath.
I'm playing this long to at least $3 and don't care how long it takes.
Anyone else notice RAD got a "buy" on CNBC Fastmoney a couple days ago?
There seems to be only one struggle here, to wear us remaining stubborn foolish shareholders out until we quit. The problem to the powers that be who must hold a billion+ shares, it seems now documented those that remain have lost so much feel, heck may as well lose it all. (Documented by the minimal daily trading, 25-1M shares traded in a day is nothing for this POS). I know that's how I feel.
Eventually I hope they'll have to figure out how to raise the Titanic, even by another pump...then maybe we'll dump. If it settles on the ocean floor, they screw themselves too.
Have we more stubborn ... or simply able to hold our breath longer from inhaling the napalm?
You're fine, you just bought approximately in the middle of the old or present channel. I calculate $2.23 as the new low in the channel and expect it to keep slowly creeping up to some new high in the $2.70 area....unless something happy happens of course!
Awesome article, thanks!
"Rite Aid today unveiled the "new Rite Aid," a small but nimble, bicoastal regional chain that executives told the 36th Annual J.P. Morgan Healthcare Conference on Wednesday will have the same buying power over the next 10 years of its one-time suitor Walgreens Boots Alliance. Though the chain has recently become deleveraged due to the 1,932 stores sold to Walgreens, company leaders said they have plans to invest that new-found financial flexibility into the front-end experience of its remaining 2,569 stores, 63% of which already represent the better-performing Wellness store format.
Leading the charge is Kermit Crawford, Rite Aid president and COO, an experienced retail pharmacy executive who over the past several months has become more familiar with the talent pool at Rite Aid.
“Our biggest strength is really our people,” he said. “A hardworking, dedicated and passionate group of people that really want to build this ‘New Rite Aid.’”
Crawford's all-star team includes Bryan Everett, COO of Rite Aid Stores; Jocelyn Konrad, executive vice president pharmacy; Derek Griffith, executive vice president store operations; David Abelman, executive vice president marketing; Bill Jackson, senior vice president supply chain; and Bill Renz, senior vice president merchandising.
The new Rite Aid will have operations across 19 states, most notably in California, Pennsylvania and Michigan.
“The store base that we're left with is very strong,” John Standley, Rite Aid chairman and CEO said Wednesday. “We're going to have higher front-end sales [and] higher pharmacy sales per-store than the old company. We end up with a great asset base when we're done with this transaction and we're excited about where we can go moving forward."
Standley said that Rite Aid's net debt will fall from $6.7 billion as of Dec. 2 to $2.9 billion following the completion of store sales to Walgreens. Also following the deal, Rite Aid's average per-store total sales will climb from $5,725 to $6,227 and the average per-store weekly scripts filled will grow from 1,252 to 1,342.
In his presentation to J.P. Morgan, Crawford outlined six key initiatives that will help redefine Rite Aid's front-end shopping experience, including:
Immunizations. "We're having a very successful flu season program," Crawford said. "We're going to be up 9% year-over-year.";
Wellness stores. "We're really excited about the Wellness store innovations," he said, "Our front-end comps are coming in at 176 basis points and Rx 240 basis points, over the rest of our chain.";
Wellness + loyalty program. "We have over 20 million active members in our program as of the end of December," he said. "The data that we're getting from these loyalty programs is helping us to understand who [our shopper] is and why she is shopping our stores.";
Localized product assortment. "We have a tremendous opportunity when it comes to localizing our product assortment," he said. "We're going to make our stores more tailored ... to the communities that we serve, adding things like DME to certain select markets.";
Private label. "We have six brands today, over 4,000 items. We're doing over $1 billion in sales," he said. "We have a tremendous opportunity to differentiate our front-end offering through these private brand products. We know we have the quality and the standards in place. It's a matter of driving this business much greater than we have in the past."; and
Omnichannel. "Our best customers are heavily engaged in our app and our website," he said. "Our online marketing is being targeted and segmented based on this [loyalty] data that we're getting."
Across the back bench, the new Rite Aid will gain access to the WBAD generic purchasing option once the transfer of 50% of the 1,932 stores to Walgreens has been completed. "This is huge," Crawford said. "One of the concerns we've heard is ‘You're a smaller company, are you going to be able to buy as well?’ This gives us the confidence that we will be able to buy our generic purchasing at a very competitive rate."
Beyond a competitive generics purchasing position, Rite Aid will be counting on its PBM EnvisionRx, along with the 22 million lives covered, to serve as a significant point of difference in the markets Rite Aid serves. "EnvisionRx will serve as a growth engine for our entire company," Crawford said. "[It's] a full-service PBM platform with all capabilities in-house with a comprehensive suite of offerings that will be offered both as a bundle and an 'a la carte.'"
Crawford added EnvisionRx is the gateway to a stronger presence in specialty, where today Rite Aid is managing approximately 5,000 patients. "We have to be a player in that specialty business," he said. "We have access to the limited distribution drugs, all of the injections, infusions, oral and biologicals and a tremendous cost-savings program around managing waste and improving outcomes and adherence. One of the assets we have is Health Dialog. Health Dialog has the analytics, the research and predictive modeling that we think can differentiate our EnvisionRx offering and help us better manage these high-cost patients."
60 days chart looks fantastic, is this why shorty quit and THE reason for today's move? Comparing activity to a month ago, I'm wondering if volume tomorrow will double from today...
Great post benny, I fully agree
Anyone know how to compare RiteAid #s with CVS &/or Walgreens on a West coast regional basis? Out here in California, observationally at least, RAD seems just as popular/big/dominant as those guys.
In rare defense of HR, I'd say such posts do not contain "RUMOR". Instead, I dare to classify them as IMPRESSIONS that us SH minions like myself have come to believe regarding JJ.
Understand even if you have "insidetruth", the same blood or even if you live in his house.... unless you're inside JJ's head, what do you really know?
A third of a cent, something big appears about to happen this quarter...
"Somebody" = ?
"They" = ?
"Them" = ?
Too late for 1.5, imho has retraced as far as it will, now takes another shot at punching through 2.2
Someone forgot to close the lights...Geo?
That would certainly make this board unique...
MDMN is like a falling rock getting more and more diluted as it gets closer to ground zero...blind shareholders only hope now is that the controlled storyline of first a theorized, now inevitable Auryn IPO actually happens before the collision.
No kidding. Only one "thing" laughable about this board.
I've lost count, is this the 46th or is the 47th time we've been told the ugly past is behind us and the future is bright?
We're being diluted to nothingness.
Same, thanks for the honesty Beth. One has to hope that much of the selling that brought us to sub penny level was a result of that lying stealing bastard (or bastards). In any event, the selling at least feels like it stopped right around the time of the discovery.
Beth, are you now a bull on mdmn?
By active and continued omission we continue to receive proof dysfunction remains here
Things never looked better! For a mere $100, Picasso no longer paints the tape at the end of the day, he/she is charging this whole thing to the moon! We're in the green!
Per your request, here's a sample regular "insider" email, obviously from around November 2015:
Regardless of how much factual money any cracked fat old man believes non insiders made on MDMN....that amount is nothing to the amount of money non insiders lost....
but don't pay attention to that...
or the volume of interest in it.....
pay attention and hype up the FACT we were in the green today!
100,000 shares traded today, up 1%. $10 divided amongst 3 billion shareholders....
hip hip..........................
hoorah?
Beth,
I think I have to disagree with you, Les could be the imbecile who does post here as previously theorized.
Think about it, if Les is still selling or even thinking about it, he needs somebody to buy. He'd be selling the idea of buying at a "discount" bargain. He probably thinks he's shielded because he has some crap email address and could never be uncovered.
Could it be? Les is a tech genius!
YEEHAW we're in the GREEN everyone!
...2,000 shares traded...fairly rounded off to someone tipping the doorman $20.00....Thanks Ulander....Thanks Les....Thanks especially to monkeys for without that light we'd be in the dark.